Navigation Links
Immucor Appoints Chief Operating Officer
Date:7/16/2009

NORCROSS, Ga., July 16 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that Geoffrey S. Crouse has been named Vice President and Chief Operating Officer.

In this newly created position, Mr. Crouse will have worldwide responsibility for manufacturing and distribution as well as sales, marketing and customer service. Mr. Crouse will report to Dr. Gioacchino De Chirico, Immucor's President and Chief Executive Officer.

Mr. Crouse previously served as vice president of the life sciences business at Millipore Corporation, a NYSE-traded provider of technologies, tools and services for the global life science industry. In this role, he led the Life Science Strategic Business Unit, a global laboratory consumables and reagents business, and held responsibility for manufacturing, research and development, sales and marketing. During his tenure, Mr. Crouse improved manufacturing operations, led multiple acquisitions and integrations while increasing sales and profitability for the business unit.

"We are pleased to strengthen our management team with the addition of Geoff," stated Dr. De Chirico. "His experience and results-oriented track record will enhance our efforts to improve transfusion medicine through automation. Our commitment to improving blood bank operations and patient safety benefits our customers, employees and shareholders."

Mr. Crouse's experience includes various leadership roles in both the U.S. and internationally. Prior to joining Millipore, Mr. Crouse worked at Roche, a Swiss Exchange-traded leader in the pharmaceuticals and diagnostics industries, where he most recently led market development and government affairs for the diagnostics division based in Basil, Switzerland.

Mr. Crouse holds a Masters of Business and a Masters of Public Health from the University of California, Berkeley as well as a Bachelor of Arts degree from Boston College.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
2. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
3. Immucor Announces Fiscal Year 2010 Guidance
4. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
5. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
6. Immucor Receives Subpoena From Department of Justice
7. Immucor Announces Fiscal Third Quarter Results
8. Immucor Announces New Vice President, Operations
9. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
10. Immucor Closes BioArray Acquisition
11. Immucor Schedules Fiscal 2009 Guidance Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... Berkeley, and other leading institutions in announcing the launch of the Leadership ... the way animals are raised for food. , Founding members of the Leadership ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
Breaking Medicine Technology: